WaveMan
WaveMan · Company
XHG · Xchange Tec.Inc
> Search tickers & screens ⌘K
LIVE
← All companies

XHG XChange TEC.INC (XHG) Insider Trading, Ownership & Congress Trades

Insurance · Insurance agents, brokers & service · CIK 0001769256
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
2
13F, latest reported quarter

XChange TEC.INC insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for XChange TEC.INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
HRT FINANCIAL LP
BUY
2025-01-21 SECtraded 2025-01-17
78,275
$93.9K
-81.1%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (2 buys, 1 sale), the last on Jan 16, 2025.
  • -47.1% median (-47.1% mean) 90-day return after 2 previous buys.
  • No other insider bought within 30 days.
  • 2 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP bought about $93.9K of XHG on Jan 17, 2025, the largest insider purchase at the company on our record; 2 funds added in the latest 13F quarter.
HRT FINANCIAL LP
BUY
2025-01-21 SECtraded 2025-01-16
10,654
$9.8K
-81.1%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Dec 30, 2024.
  • The trade is 38.1% of the 27,983 shares held after it.
  • No other insider bought within 30 days.
  • 2 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP bought about $9.8K of XHG on Jan 16, 2025; 2 funds added in the latest 13F quarter.
HRT FINANCIAL LP
SELL
2025-01-02 SECtraded 2024-12-30
20,385
$18.3K
-76.0%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Dec 27, 2024.
  • The trade is 209.7% of the 9,720 shares held after it.
  • No other insider sold within 30 days.
  • 2 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP sold about $18.3K of XHG on Dec 30, 2024, the largest insider sale at the company on our record; 2 funds added in the latest 13F quarter.
HRT FINANCIAL LP
BUY
2025-01-02 SECtraded 2024-12-27
12,027
$10.7K
-76.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 40.0% of the 30,105 shares held after it.
  • No other insider bought within 30 days.
  • 2 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP bought about $10.7K of XHG on Dec 27, 2024, the largest insider purchase at the company on our record; 2 funds added in the latest 13F quarter.
4 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
2 funds bought in last quarter
Revenue
+24.9% year over year
more than 78% of Insurance
Margin
-204.9% net margin
below 97% of Insurance
Buybacks
no share repurchases reported
Short interest
0.3% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
the lowest in Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch XHG

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+274.0%12M
-23%+106%+234%+362%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns XHG: institutional holders (13F)

13F holdings, latest reported quarter
SUSQUEHANNA INTERNATIONAL GROUP, LLP
12,432 sh
$11.2K
UBS Group AG
728 sh
$670
MORGAN STANLEY
15 sh
$14

Congress trades in XHG

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

XHG planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 2 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRALHCCRVLHGTYKNSLAFLTRVMKLOSCRGL

XHG financials

Revenue growth
+24.9%
XBRL, annual
Net margin
-204.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Cash flow to debt
n/a
needs four quarters of operating cash flow
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
$96.8B
market value at close 2026-10-27 on 2022-09-30 shares, plus long-term 2022-03-31 plus current 2026-03-31, minus cash 2026-03-31
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-092024-092023-092022-09
Revenue$365.3M$288.4Mn/a$652.3M
Gross profit$8.0M$13.5Mn/an/a
Operating income-$720.3M-$588.8M-$23.5M-$29.4M
Net income-$748.4M-$226.8M-$71.3M$820.0M
EPS (diluted)0.000.000.000.00
Operating cash flow-$11.7M-$9.8M-$39.9M-$44.3M
Cash$10.9M$8.1M$286.0K$563.0K
SEC XBRL, fiscal years, as known on 2026-10-28

XHG Stock Sonar score 2/7 axes

Find similar shapesCompare
Growth
78
Inputs
  • Revenue growth, YoY+24.9% · 78 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
92
Inputs
  • Short interest, % of float+0.3% · 92 pct, sector of 138
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
5 not measured: Profitability, Financial health, Insider conviction, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: equity is zero or negative, the ratio has no meaning; needs four quarters of operating cash flow
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies